1. Efficacy of the RTS,S/AS01E vaccine wanes over four years.
2. The decline in efficacy is greater in areas of higher malaria exposure.
The RTS,S/AS01E is currently the most developed malaria vaccine, with its phase 3 trial slated to end in December 2014. Results continue to show that the vaccine...